Koyfin Home > Directory > Health Care > Amicus Therapeutics > Cash from Investing Activities

Amicus Therapeutics Cash from Investing Activities Chart (FOLD)

Amicus Therapeutics annual/quarterly Cash from Investing Activities from 2006 to 2018.
  • Amicus Therapeutics Cash from Investing Activities for the quarter ending September 09, 2018 was $114m a 54.98% increase of 63m year over year
  • Amicus Therapeutics Cash from Investing Activities for the last 12 months ending September 09, 2018 was $-6m a -2,819.71% increase of 165m year over year
  • Amicus Therapeutics Annual Cash from Investing Activities for 2017 was $-171m a 97.37% decrease of -167m from 2016
  • Amicus Therapeutics Annual Cash from Investing Activities for 2016 was $-5m a -3,123.40% increase of 141m from 2015
  • Amicus Therapeutics Annual Cash from Investing Activities for 2015 was $-145m a 26.33% decrease of -38m from 2014
Other Cash Flow Metrics:
  • Amicus Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-133m a 44.44% decrease of -59m year over year
  • Amicus Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-78m a 35.32% decrease of -28m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Cash from Investing Activities Data

09/2018$114m
06/2018$11m
03/2018$-183m
12/2017$52m
09/2017$-174m
06/2017$44m
03/2017$-92m
12/2016$35m
09/2016$-30m
06/2016$-10m

Annual FOLD Cash from Investing Activities Data

2017$-171m
2016$-5m
2015$-145m
2014$-107m
2013$26m
2012$-39m
2011$46m
2010$-19m
2009$32m
2008$22m